Table 3.
Reintubation (%) | 7 (2.9) |
Reoperation for a significant residual VSD (%) | 5 (2.1) |
Refixation of the sternum (%) | 6 (2.5) |
Wound infection (%) | 4 (1.6) |
Postpericardiotomy syndrome (%) | 4 (1.6) |
Chylothorax (%) | 1 (0.4) |
Heart block | |
Transient (%) | 12 (4.9) |
Permanenta (%) | 2 (0.8) |
Seizure (%) | 1 (0.4) |
Rehospitalization (%) | 6 (2.5) |
Circulatory arrest (%) | 0 (–) |
Stroke (%) | 0 (–) |
Renal failure (%) | 0 (–) |
Neurological deficit (%) | 0 (–) |
Paralyzed diaphragm (%) | 0 (–) |
Need for postoperative mechanical circulatory support | 0 (–) |
Death (%) | 0 (–) |
Total complicationsb (%) | 38 (15.6) |
Total major adverse eventc (%) | 7 (2.9) |
aRequiring pacing by a pacemaker
bNumber of patients with one or more complications
cAccounted as major adverse events are reoperation, permanent heart block, circulatory arrest or death